SOPHiA GENETICS to Participate in Fireside Chat at the 44th Annual TD Cowen Health Care Conference
February 22 2024 - 8:45AM
SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and
a leader in data-driven medicine, today announced Co-founder and
Chief Executive Officer, Dr. Jurgi Camblong, and Chief Financial
Officer and Chief Operating Officer, Ross Muken, will participate
in a fireside chat at the 44th Annual TD Cowen Health Care
Conference on Wednesday, March 6, 2024, at 10:30 a.m. EDT.
The fireside chat will be webcast live on the SOPHiA
GENETICS Investor Relations website. Additionally, a replay will be
available on the website after its completion.
About SOPHiA GENETICS
SOPHiA GENETICS (Nasdaq: SOPH) is a software company dedicated
to establishing the practice of data-driven medicine as the
standard of care and for life sciences research. It is the creator
of the SOPHiA DDM™ Platform, a cloud-native platform capable of
analyzing data and generating insights from complex multimodal data
sets and different diagnostic modalities. The SOPHiA DDM™ Platform
and related solutions, products, and services are currently used by
a broad network of hospital, laboratory, and biopharma institutions
globally. For more information, visit SOPHiAGENETICS.COM, or
connect on X, LinkedIn, Facebook,
and Instagram. Where others see
data, we see answers.
Investor Contact
Kellen Sanger
IR@sophiagenetics.com
Media Contact
Kelly Katapodis
media@sophiagenetics.com
Sophia Genetics (NASDAQ:SOPH)
Historical Stock Chart
From Apr 2024 to May 2024
Sophia Genetics (NASDAQ:SOPH)
Historical Stock Chart
From May 2023 to May 2024
